• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Pharmaceutical Outsourcing Opportunities Post Launch: Contract Manufacturing, and Sales and Marketing

$3,500.00 – $7,000.00

Clear
SKU: KLI962299 Categories: Drug Discovery Market Reports, Manufacturing & Packaging, Pharmaceuticals Market Research Pages: 232
  • Description
  • Table of Contents
  • Latest reports

Description

After decades of sustained growth and profitability, the pharmaceutical industry has been positioned as one of the few recession proof industries based on its performance through multiple economical cycles. In recent years, there have been visible strains in the pharmaceutical business. With a downturn in fortunes, many pharmaceutical companies are searching for business solutions to streamline operations and cut costs as they strive to continue generating above-average shareholder returns.

Outsourcing has become an integral, ongoing element of pharmaceutical companies’ business strategy. In the past year, Kalorama Information has conducted studies on pharmaceutical outsourcing in both the drug discovery and drug development phases. In this current study, we take a look at outsourcing even later in the drug life-cycle: contract manufacturing and contract marketing and sales.

The use of third parties to develop and manufacture drugs was confined to providing access to resources not available internally or to providing resources during peak times. Today, however, outsourcing manufacturing is a first-line decision. It is estimated that the U.S. market for outsourced pharmaceutical manufacturing is growing at the rate of 10 to 12% annually. Pharmaceutical companies will continue to fuel much of this growth as they outsource an increasing number of products and services. Biotechnology companies, which have almost doubled in number during the past five years, also contribute to this trend as they seek ways of bringing their products to market without making capital investments in their own manufacturing facilities. Biopharmaceutical manufacturing, a complex and expensive operation, is a major factor in this market. The use of outsourced expertise and capacity in biopharma was one of the major areas of study in this project.

Contract manufacturing can be categorized into three broad areas: biomanufacturing, primary, and secondary manufacturing. Biomanufacturing includes manufacturing of protein-based biopharmaceutical products. Process development in biomanufacturing is complex and involves expertise molecular biology, purification and advanced chemistry. Primary manufacturing involves the custom manufacturing of pharmaceutical ingredients. This sector includes fine chemicals, APIs, custom chemicals and intermediates. Secondary manufacturing, from the point of view of our report, is concentrated on sterile manufacturing, which produces sterile injectable drugs, and specific oral drugs, which require lyophilization.

Historically, pharmaceutical companies maintained their own sales and marketing divisions. However, pharmaceutical companies and especially smaller developers are increasingly turning to contract sales force organizations to provide the extra market muscle they need. The result has been a strong market for companies supplying these services. CSOs offer several benefits for clients. They allow companies to economically reach physicians they would not ordinarily be able to call on, providing additional sales coverage tailored to a specific need, whether it is territorial or market segment in nature. This is the first study to examine and analyze the market for contract sales.

Table of Contents

Chapter One: Executive Summary

  • Challenges Facing the Pharmaceutical Industry
  • Strategies to Address Challenges
  • Contract Manufacturing
  • Biopharmaceutical Manufacturing
  • Contract Primary and Secondary Manufacturing
  • Market Analysis: Contract Manufacturing
  • Contract Sales & Marketing
  • Market Analysis: Contract Sales and Marketing

Chapter Two: Meeting the Challenges of a Changing Marketplace

  • Challenges Facing the Pharmaceutical Industry

    • Meeting Investor Expectations
    • Erosion of Blockbuster Sales
    • Increased Generic Competition
    • Pricing Pressures
    • Pipelines Slowing Compared to ROI
  • Strategies to Address Challenges

    • Mergers and Acquisitions
    • Strategic Outsourcing
    • Restructuring Manufacturing Operations
    • Reducing the Size of In-House Sales Force

Chapter Three: Contract Manufacturing

  • Industry Overview
  • Major Drivers of Contract Manufacturing
  • Key Competing Factors for Contract Manufacturers
  • Biopharmaceutical Manufacturing

    • Characteristics of Biopharmaceutical Manufacturing
    • Types of Contractors Involved in Biomanufacture
    • Biopharmaceutical Manufacturing Demand Increasing
    • Is There a Biomanufacturing Capacity Shortage?
    • Alternative Methods of Producing Biopharmaceuticals
    • Transgenic Products in Clinical Trials
    • Contract Biopharmaceutical Manufacturing
    • Major CMOs Expanding Operations to Manufacture Biologics
  • Contract Primary And Secondary Manufacturing

    • Contract Primary Manufacturing
    • Outsourcing of Fine Chemicals Slowing
    • Asian/Indian Threat
    • Ramping up the Technology Toolbox to Gain a Competitive Edge
    • Chiral Technologies
    • Oligonucleotides and Peptides Capabilities
    • Specialized Niches Offer Opportunity
    • Exploring Other Growth Opportunities
    • Contract Secondary Manufacturing
    • Demand for Sterile Manufacturing Capabilities on Increase
    • Business is Brisk for Contract Package Manufacturing
  • Market Analysis: Contract Manufacturing

    • Contract Primary Manufacturing
    • Niche Markets Remain Stable
    • Strategies to Maintain Profitability in a Sluggish Market
    • Contract Primary Manufacturing Market and Forecast
    • Contract Primary Manufacturing Market Share
    • Contract Secondary Manufacturing
    • Gaining Market Share Through Acquisitions and Collaborative Agreements
    • Contract Secondary Manufacturing Market and Forecast
    • Contract Secondary Manufacturing Market Share
    • Contract Biomanufacturing
    • Contract Biomanufacturing Market and Forecast
    • Contract Biomanufacturing Market Share

Chapter Four

  • Contract Sales & Marketing
  • Contract Sales Organizations
  • Government Regulations Regarding Sales and Marketing
  • Drivers of Outsourcing Sales & Marketing

    • Broad-based Portfolio of Marketing and Sales Services
    • Maximize Efficiency of Sales and Marketing
    • Speed and Flexibility
    • Provide Sales Team to Companies with No In-House Sales/Marketing Expertise
  • Selecting A CSO
  • Services Offered by CSOs

    • Integrated Sales Force Recruitment, Training and Management
    • Implementation Services
    • Technical Support Service
    • Data Center Services
    • Call Center Services
    • Hardware Support Services
    • Training and Educational Services
    • Product, Sample and Literature Fulfillment
    • Telemarketing
    • Brand/Portfolio Analytics and Forecasting
    • Strategic and Tactical Planning
    • Strategic Consulting
  • CSO Client Contracts
  • Improving Sales Force Effectiveness Through Technology-Based Solutions

    • E-detailing
    • Virtual Live e-Detailing
    • Scripted e-Detailing
    • Physician Portal e-Detail
  • Customer Relationship Management

    • Mobile Technology
    • Outsourcing CRM-Related Services
    • Information Management
    • Business Intelligence & Analytics
    • Commercial Operations
  • Market Analysis: Contract Sales and Marketing

    • Industry Characteristics
    • Market Environment
    • CSO Market and Forecast
    • CSO Market Share
  • Strategies for Gaining Market Share

Chapter Five: Contract Manufacturing Company Profiles

  • Albemarle Corporation

    • History and Lines of Business
    • Contract Manufacturing
    • Financial Information
  • Avecia, Inc.

    • History and Lines of Business
    • Contract Manufacturing Services
    • GMP Manufacture
    • Financial Information
  • Bachem Holding Ag

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information
  • Baxter Pharmaceutical Solutions LLC

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information
  • Ben Venue Laboratories

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information
  • Bioreliance Corporation

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information:
  • Biovectra DCL

    • History and Lines of Business
    • Contract Manufacturing Services
  • Boehringer-Ingelheim

    • History and Lines of Business
    • Contract Manufacturing
    • Financial Information
  • Cambrex Corporation

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information:
  • Cardinal Health Contract Manufacturing

    • History and Lines of Business
    • Contract Manufacturing and Packaging Services
    • Financial Information:
  • Chesapeake Biological Laboratories

    • History and Lines of Business
    • Contract Manufacturing Services
  • DPT Laboratories, Ltd.

    • History and Lines of Business
    • Contract Manufacturing Services
  • DSM Pharmaceuticals, Inc.

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information
  • Degussa AG

    • History and Lines of Business
    • Contract Manufacturing
    • Financial Information
  • Dowpharma

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information
  • Draxis Health, Inc.

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information:
  • Genzyme Pharmaceuticals

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information
  • Girindus AG

    • History and Lines of Business
    • Contract Manufacturing Services
  • Glatt Air Techniques, Inc.

    • History and Lines of Business
    • Contract Manufacturing Services
  • HollisterStier Contract Manufacturing

    • History and Lines of Business
    • Contract Manufacturing Services
  • Hospira One 2 One

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information
  • Laureate Pharma

    • History and Lines of Business
    • Contract Manufacturing Services
  • Lonza Group Ltd

    • History and Lines of Business
    • Contract Manufacturing Services: Lonza Biologics
    • Analytical Services
    • Financial Information
  • Lyne Laboratories

    • History and Lines of Business
    • Contract Manufacturing Services
  • Mallinckrodt Pharmaceuticals

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information
  • Patheon, Inc
    .

    • History and Lines of Business
    • Contract Manufacturing Services
    • Financial Information
  • Rhodia Pharma Solutions

    • History and Lines of Business
    • Contract Manufacturing
    • Financial Information
  • Wellspring Pharmaceutical

    • History and Lines of Business
    • Contract Manufacturing Services

Chapter Six: Contract Sales and Marketing Company Profiles

  • Cardinal Health Contract Sales and Marketing

    • History and Lines of Business
    • Contract Sales and Marketing
    • Financial Information
  • Dendrite International, Inc.

    • History and Lines of Business
    • Contract Marketing and Sales Support Services
    • Financial Information
  • Innovex

    • History and Lines of Business
    • Contract Sales and Marketing Services
    • Financial Information
  • Medical Affairs, Marketing & Communications

    • History and Lines of Business
    • Contract Marketing and Market Research
      • Late Phase Development Studies
      • Pre-Launch and Post-Launch Services
      • Meeting Management and Publication Services
      • Financial Information
  • OnCall

    • History and Lines of Business
    • Contract Sales Services
    • Marketing Services
  • PDI, Inc.

    • History and Lines of Business
    • Contract Sales and Marketing Services
    • Financial Information
  • Ventiv Health U.S.

    • History and Lines of Business
    • Contract Sales and Marketing Services
    • Financial Information

 

Appendix A: Company Directory

List of Exhibits

Chapter One: Executive Summary

  • Exhibit 1-1: Respondents’ Biopharmaceutical Manufacturing Operations
  • Exhibit 1-2: Percent Companies Outsourcing at Least Some Manufacturing Production, 2003 And 2008, by System
  • Exhibit 1-3: A Selection of CMOs Increasing Sterile Manufacturing Capacity Company, Location, Square Feet Added, and Investment
  • Exhibit 1-4: Global Contract Manufacturing Market by Type Primary, Secondary, Biomanufacturing 2002-2010
  • Exhibit 1-5: Global Contract Sales Organization Market 2000-2010

Chapter Three: Contract Manufacturing

  • Exhibit 3-1: Manufacturing Operations Contracted byPharmaceutical and Biotechnology Companies
  • Exhibit 3-2: Contract Manufacturing Subsidiaries of Pharmaceutical and Biotechnology Companies Competing in the Outsourcing Market
  • Exhibit 3-3: Respondents’ Biopharmaceutical Manufacturing Operations
  • Exhibit 3-4: Sales of Select Biopharmaceuticals on the Market
  • Exhibit 3-5: Percent Companies Outsourcing at Least Some Manufacturing Production, 2003 and 2008, by Manufacturing System
  • Exhibit 3-6: Selected CMOs Expanding Biomanufacturing Capacity, 2000-2004, Company, Location, Square Feet Added, and Investment
  • Exhibit 3-7: Manufacturing Processes Developed for Top Ten Blockbuster Drugs by Indian Companies
  • Exhibit 3-9: Global Contract Manufacturing Market by Type Primary, Secondary, Biomanufacturing 2002-2010
  • Exhibit 3-10: Global Contract Primary Manufacturing Market 2000-2010
  • Exhibit 3-11: Contract Primary Manufacturing Market Share 2003
  • Exhibit 3-12: A Selection of CMOs Increasing Sterile Manufacturing Capacity Company, Location, Square Feet Added, and Investment
  • Exhibit 3-13: Global Contract Secondary Manufacturing Market, 2000-2010
  • Exhibit 3-14: Contract Secondary Manufacturing Market Share 2003
  • Exhibit 3-15: Global Contract Biomanufacturing Market 2000-2010
  • Exhibit 3-16: Contract Biomanufacturing Market Share 2003 by Leading Competitor

Chapter Four: Contract Sales & Marketing

  • Exhibit 4-1: Return on Investment per Dollar Spent for the Top 14 Pharmaceutical Companies 1998-2001
  • Exhibit 4-2: Key Contract Sales Organization Solutions to Maximize ROI
  • Exhibit 4-3: Global Contract Sales Organization Market 2000-2010
  • Exhibit 4-4: Contract Sales Organization Market Share by Leading Competitor 2003

 

    In Vitro Toxicology Market
    July 19, 2018
    100 Companies in Contract Pharmaceutical Research – White Paper
    March 27, 2018
    Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 8th Edition
    March 20, 2018
    Outsourcing in Drug Discovery, 7th Edition
    April 26, 2016

Related products

  • Placeholder image

    Worldwide Market for Prescription Dermatological Drugs – 4th Edition, The

    $3,500.00 – $7,000.00
  • Placeholder image

    Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline

    $3,500.00 – $7,000.00
  • Placeholder image

    U.S. Market for OTC Diet Aids, The

    $3,000.00 – $6,000.00
  • Placeholder image

    OTC Women’s Health: A Supplement to Women’s Health, 3rd Edition

    $1,496.00 – $2,992.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Monoclonal Antibodies in Cancer Therapy: Emerging Products and MarketsAmbulatory Infusion Pumps in Pain Management: A Market Briefing
Scroll to top